Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Herman F Staats

Showing results (61-70 of 78) with videos related to

Pageof 8
Sort By:
Journal of Virology|November 16, 2004
Gender differences in human immunodeficiency virus type 1-specific CD8 responses in the reproductive tract and colon following nasal peptide priming and modified vaccinia virus Ankara boostingJames W Peacock, Sushila K Nordone, Shawn S Jackson, et al.
Clinical and Vaccine Immunology : CVI|September 1, 2006
Generation of mucosal anti-human immunodeficiency virus type 1 T-cell responses by recombinant Mycobacterium smegmatisJae-Sung Yu, James W Peacock, Stacie Vanleeuwen, et al.
AIDS Research and Human Retroviruses|November 25, 2010
Scarcity or absence of humoral immune responses in the plasma and cervicovaginal lavage fluids of heavily HIV-1-exposed but persistently seronegative womenJiri Mestecky, Peter F Wright, Lucia Lopalco, et al.
Journal of Virology|May 10, 2019
Optimized Mucosal Modified Vaccinia Virus Ankara Prime/Soluble gp120 Boost HIV Vaccination Regimen Induces Antibody Responses Similar to Those of an Intramuscular RegimenDorothy I Jones, Justin J Pollara, Brandi T Johnson-Weaver, et al.
Vaccine|August 19, 2004
A comparative evaluation of nasal and parenteral vaccine adjuvants to elicit systemic and mucosal HIV-1 peptide-specific humoral immune responses in cynomolgus macaquesMichael A Egan, Siew Yen Chong, Michael Hagen, et al.
The Journal of Infectious Diseases|March 28, 2003
Prolonged CD4+ cell/virus load discordance during treatment with protease inhibitor-based highly active antiretroviral therapy: immune response and viral controlSusan A Sufka, Guido Ferrari, Victoria E Gryszowka, et al.
Science (New York, N.Y.)|April 30, 2005
Cardiolipin polyspecific autoreactivity in two broadly neutralizing HIV-1 antibodiesBarton F Haynes, Judith Fleming, E William St Clair, et al.
Vaccine|May 16, 2002
Increased immunogenicity of HIV envelope subunit complexed with alpha2-macroglobulin when combined with monophosphoryl lipid A and GM-CSFHua Xin Liao, George J Cianciolo, Herman F Staats, et al.
SLAS Discovery : Advancing Life Sciences R & D|March 28, 2019
Identification of Novel Mast Cell Activators Using Cell-Based High-Throughput ScreeningHae Woong Choi, Cliburn Chan, Ivo D Shterev, et al.
Frontiers in Immunology|April 10, 2023
Development of a broadly active influenza intranasal vaccine adjuvanted with self-assembled particles composed of mastoparan-7 and CpGLuis Ontiveros-Padilla, Cole J Batty, Dylan A Hendy, et al.
Pageof 8

Showing results (61-70 of 78) with videos related to

Sort By:
Pageof 8
Journal of Virology|November 16, 2004
Gender differences in human immunodeficiency virus type 1-specific CD8 responses in the reproductive tract and colon following nasal peptide priming and modified vaccinia virus Ankara boostingJames W Peacock, Sushila K Nordone, Shawn S Jackson, et al.
Clinical and Vaccine Immunology : CVI|September 1, 2006
Generation of mucosal anti-human immunodeficiency virus type 1 T-cell responses by recombinant Mycobacterium smegmatisJae-Sung Yu, James W Peacock, Stacie Vanleeuwen, et al.
AIDS Research and Human Retroviruses|November 25, 2010
Scarcity or absence of humoral immune responses in the plasma and cervicovaginal lavage fluids of heavily HIV-1-exposed but persistently seronegative womenJiri Mestecky, Peter F Wright, Lucia Lopalco, et al.
Journal of Virology|May 10, 2019
Optimized Mucosal Modified Vaccinia Virus Ankara Prime/Soluble gp120 Boost HIV Vaccination Regimen Induces Antibody Responses Similar to Those of an Intramuscular RegimenDorothy I Jones, Justin J Pollara, Brandi T Johnson-Weaver, et al.
Vaccine|August 19, 2004
A comparative evaluation of nasal and parenteral vaccine adjuvants to elicit systemic and mucosal HIV-1 peptide-specific humoral immune responses in cynomolgus macaquesMichael A Egan, Siew Yen Chong, Michael Hagen, et al.
The Journal of Infectious Diseases|March 28, 2003
Prolonged CD4+ cell/virus load discordance during treatment with protease inhibitor-based highly active antiretroviral therapy: immune response and viral controlSusan A Sufka, Guido Ferrari, Victoria E Gryszowka, et al.
Science (New York, N.Y.)|April 30, 2005
Cardiolipin polyspecific autoreactivity in two broadly neutralizing HIV-1 antibodiesBarton F Haynes, Judith Fleming, E William St Clair, et al.
Vaccine|May 16, 2002
Increased immunogenicity of HIV envelope subunit complexed with alpha2-macroglobulin when combined with monophosphoryl lipid A and GM-CSFHua Xin Liao, George J Cianciolo, Herman F Staats, et al.
SLAS Discovery : Advancing Life Sciences R & D|March 28, 2019
Identification of Novel Mast Cell Activators Using Cell-Based High-Throughput ScreeningHae Woong Choi, Cliburn Chan, Ivo D Shterev, et al.
Frontiers in Immunology|April 10, 2023
Development of a broadly active influenza intranasal vaccine adjuvanted with self-assembled particles composed of mastoparan-7 and CpGLuis Ontiveros-Padilla, Cole J Batty, Dylan A Hendy, et al.
Pageof 8